Relenza Divorce Coming? Developer Sues GSK For Lack Of Support

Biota, the Australian firm which developed the flu treatment, says that GlaxoSmithKline has stopped promoting Relenza and has declined to expand its label, allowing market share to “freefall.”

More from Archive

More from Pink Sheet